Skip to search formSkip to main contentSkip to account menu

Mestinon

Known as: Mestinon Bromide 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (2)

PyridostigminePyridostigmine Bromide
Pyridostigmine Bromide 12 MG/ML Oral Solution [Mestinon]Pyridostigmine Bromide 180 MG Extended Release Oral Tablet [Mestinon]Pyridostigmine Bromide 60 MG Oral Tablet [Mestinon]Pyridostigmine Oral Tablet [Mestinon]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Oculopharyngeal muscular dystrophy misdiagnosed as myasthenia gravis: Case report and review of literature
Oculopharyngeal muscular dystrophy misdiagnosed as myasthenia gravis: Case report and review of literature 
2009
2009
Effect of pyridostigmine (Mestinon) on human platelet aggregation.
INTRODUCTION Normal platelet functions are critical for achieving primary haemostasis. Numerous medications have been shown to… 
2008
2008
Can neonatal myasthenia gravis be predicted?
Abstract Aim: To determine any association between history of mothers with myasthenia gravis (MG) and the occurrence of neonatal… 
1970
1970
Über die Manifestation einer Myasthenia gravis pseudoparalytica nach Thymomektomie
Summary2 weeks after the successful total exstirpation of a benign thymoma a 42-year-old patient developed at first bulbar, then… 
1967
1967
Pyridostigmin (mestinon) as an antagonist of d-tubocurarine.
The effects of pyridostigmin were compared with those of edrophonium and neostigmine in anesthetized patients. Pyridostigmin was… 
1959
1959
Treatment of myasthenia gravis with prolonged‐action Mestinon
WITH THE RECENT INTRODUCTION of Mestinon ( pyridostigmine bromide) and Mytelase (ambenonium chloride), considerable progress has… 
1957
1957
Treatment of myasthenia gravis; prolonged action with multiple-dose tablets of neostigmine bromide and mestinon bromide.
The anticholinesterase drugs used in treating myasthenia gravis do not have a prolonged action. The ordinary dosage forms must be… 
1956
1956
Treatment of myasthenia gravis with mestinon bromide.
• The diagnosis of myasthenia gravis was made in 165 patients whose symptoms were either aggravated by one-tenth of the minimal… 
1955
1955
Pharmacology of the anticholinesterase drugs; mestinon, prostigmin, tensilon and TEPP.
1955
1955
Advantages of pyridostigmine bromide (mestinon) and edrophonium chloride (tensilon) in the treatment of transitory myasthenia gravis in the neonatal period.
THIS paper emphasizes the value of recognizing the symptoms of myasthenia gravis, so that appropriate treatment may be given to… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)